Findings

What do systematic reviews say?

14 questions · 14 findings · 1 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 8 · 57.1%GRADE not reported 0 · 0%Very low 1 · 7.1%Low 5 · 35.7%Moderate 0 · 0%High 0 · 0%

Montelukast vs placebo

Change (improvement) in disease severity (4 to 8 weeks) SMD (modified EASI score and SASSAD) · eczema

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 131 participants
Low

Montelukast vs Conventional treatment

Adverse effects (4 to 6 weeks) · eczema

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 63 participants
Low

Montelukast vs Conventional treatment

Corticosteroid requirements · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs Conventional treatment

Reduction of pruritus · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs Conventional treatment

Improvement in quality of life · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs Conventional treatment

Need for emollient use · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs placebo

Effect of long‐term control (> 3 months) · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs placebo

Adverse effects (4 to 8 weeks) · eczema

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 131 participants
Low

Montelukast vs placebo

Corticosteroid requirements · eczema

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Montelukast vs placebo

Reduction of pruritus · eczema

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Montelukast vs placebo

Improvement in quality of life · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs placebo

Need for emollient use · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs Conventional treatment

Change (improvement) in disease severity (4 weeks) SCORAD score · eczema

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 31 participants
Very low

Montelukast vs Conventional treatment

Effect of long‐term control (> 3 months) · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found